RHODES PHARMS FDA Approval ANDA 202955

ANDA 202955

RHODES PHARMS

FDA Drug Application

Application #202955

Application Sponsors

ANDA 202955RHODES PHARMS

Marketing Status

Prescription001

Application Products

001SYRUP;ORAL2MG/5ML;10MG/5ML;30MG/5ML0BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDEBROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2020-11-05

Submissions Property Types

ORIG1Null1

TE Codes

001PrescriptionAA

CDER Filings

RHODES PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202955
            [companyName] => RHODES PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE","activeIngredients":"BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE","strength":"2MG\/5ML;10MG\/5ML;30MG\/5ML","dosageForm":"SYRUP;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/05\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-11-05
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.